Breakthrough Treatment Helps Food Allergy Sufferers Tolerate More Allergens
The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical trial found that omalizumab (Xolair) was more effective than oral…